SomaLogic, Inc. - Class A Common Stock (NQ:SLGC)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 5, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about SomaLogic, Inc. - Class A Common Stock

< Previous 1 2 3 4 Next >

Why SomaLogic Stock Dived by 10% on Wednesday ↗

October 04, 2023

The market wasn't impressed by the company's announced tie-up with Standard BioTools.

Via The Motley Fool

SLGC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of SomaLogic, Inc. Is Fair to Shareholders

October 04, 2023

From Halper Sadeh LLC

Via Business Wire

Cathie Wood's Ark Invest Sells Nearly $4M Worth Of NVIDIA Shares — Does It Herald Shift To Undervalued AI Gems? ↗

October 02, 2023

On Monday, Cathie Wood-led Ark Invest made a notable move by selling nearly $4 million worth of NVIDIA Corp (NASDAQ:NVDA) shares. This ...

Via Benzinga

Topics Artificial Intelligence

Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023 ↗

September 25, 2023

Via Benzinga

Why Shares of SomaLogic Are Up Tuesday ↗

August 15, 2023

The company showed strong revenue growth in the second quarter.

Via The Motley Fool

3 Stocks Cathie Wood Is Buying That Should Be on Your List, Too ↗

September 22, 2023

Cathie Wood is loading up on these healthcare stocks.

Via The Motley Fool

SomaLogic and Korea’s DNA Link partner to bring the 7,000-plex SomaScan® platform to the fast-growing Asia-Pacific proteomics market

September 19, 2023

DNA Link will bring the power of the largest proteomics platform available to their biomarker discovery and drug development work

From SomaLogic

Via GlobeNewswire

Cathie Wood Continues To Unload DraftKings Shares, Picks Up Robinhood Stock Worth $4.75M ↗

September 12, 2023

Via Benzinga

SomaLogic researchers identify key proteins to aid in early detection of lung, colon and breast cancer and ovarian tumors

September 12, 2023

SomaLogic’s SomaScan® platform was used to target 15 markers shared among all cancer types.

From SomaLogic

Via GlobeNewswire

SomaLogic: Q1 Earnings Insights ↗

May 11, 2023

Via Benzinga

SomaLogic expands agreement with Novo Nordisk to 2025

September 05, 2023

Novo Nordisk will extend its use of SomaLogic’s innovative proteomics technologies for research in cardiometabolic and other diseases

From SomaLogic

Via GlobeNewswire

Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

August 15, 2023

Gainers Novo Integrated Sciences, Inc. (NASDAQ: NVOS) jumped 85.4% to $0.1267 after the company and Farm 7 Group announced a joint venture for Kenya Agricultural Cooperative Project.

Via Benzinga

Paysafe, Taylor Devices, SomaLogic And Other Big Stocks Moving Higher On Tuesday ↗

August 15, 2023

U.S. stocks traded lower, with the Dow Jones falling around 300 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Home Depot, Agilent Technologies And 3 Stocks To Watch Heading Into Tuesday ↗

August 15, 2023

With U.S. stock futures trading mixed this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

SomaLogic Reports Second Quarter 2023 Financial Results

August 14, 2023

From SomaLogic

Via GlobeNewswire

SomaLogic to Announce Second Quarter 2023 Financial Results on August 14, 2023

July 24, 2023

From SomaLogic

Via GlobeNewswire

Earnings Scheduled For August 14, 2023 ↗

August 14, 2023

Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million.

Via Benzinga

SomaLogic partners with Dante Genomics to enhance clinical and research adoption of proteomics in Europe

July 24, 2023

SomaLogic’s 7,000-plex SomaScan® Platform will be used in proteomics testing at scale in Europe

From SomaLogic

Via GlobeNewswire

SomaLogic Partners with Citogen to Expand Authorized Site Program in Europe

June 12, 2023

SomaLogic’s 7,000-plex SomaScan® Platform will be used in clinical research, population health studies and nutrigenomics.

From SomaLogic

Via GlobeNewswire

SomaLogic Announces Chief Financial Officer Transition

June 06, 2023

From SomaLogic

Via GlobeNewswire

SomaLogic to Participate in the Jefferies Healthcare Conference

May 24, 2023

From SomaLogic

Via GlobeNewswire

SomaLogic Reports First Quarter 2023 Financial Results

May 11, 2023

From SomaLogic

Via GlobeNewswire

SomaLogic expands into China with groundbreaking Biostar Technology Limited Partnership

May 10, 2023

SomaLogic to deliver 7,000-plex SomaScan® Platform to researchers in attractive Chinese proteomics market

From SomaLogic

Via GlobeNewswire

SomaLogic opens their first-ever proteomics grant program to APAC life sciences researchers

May 07, 2023

From SomaLogic

Via GlobeNewswire

Earnings Scheduled For May 11, 2023 ↗

May 11, 2023

Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its...

Via Benzinga

SomaLogic, Inc. (SLGC) Shareholder Investigation: Robbins LLP is Investigating SomaLogic, Inc. on behalf of Shareholders

April 21, 2023

From Robbins LLP

Via Business Wire

SomaLogic to Announce First Quarter 2023 Financial Results on May 11, 2023

April 20, 2023

From SomaLogic

Via GlobeNewswire

PriceSmart, CarMax, Cognyte Software And Other Big Stocks Moving Higher On Tuesday ↗

April 11, 2023

U.S. stocks traded mixed, with the Dow Jones gaining over 50 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

March 29, 2023

On Wednesday, 81 companies hit new 52-week lows.

Via Benzinga

Why Kodiak Sciences Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 29, 2023

Gainers LogicMark, Inc. (NASDAQ: LGMK) shares jumped 76.1% to $0.2466 after the company announced financial results for the year ended 2022. The company reported FY22 revenue of $11.9 million.

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.